Position in NKTR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$120,840
-$17,015 QoQ
Shares Held
1,731
-9.7% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#193
of 239 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. NKTR ranks #51 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
66,580 | $16,296,786 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32,020 | $15,905,293 | |
| 3 | TECH |
BIO-TECHNE Corp
|
137,966 | $9,747,297 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,330 | $3,323,466 | |
| 5 | ARGX |
Argenx SE
|
3,495 | $3,242,555 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
38,226 | $3,115,799 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
10,103 | $2,434,518 | |
| 8 | GMAB |
Genmab A/S
|
88,420 | $2,428,896 |
All Filings in NKTR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,840 | 1,731 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $137,855 | 1,916 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $53,271 | 1,260 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $102,988 | 1,810 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $95,631 | 3,701 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $34,057 | 50,085 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $13,020 | 14,000 | Shares | Defined | 2025-02-05 | |
| 2024-09-30 | $22,100 | 17,000 | Shares | Defined | 2024-10-28 | |
| 2024-06-30 | $21,080 | 17,000 | Shares | Defined | 2024-08-07 | |
| 2023-09-30 | $30,570 | 50,950 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $29,551 | 50,950 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $41,727 | 59,610 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $139,778 | 61,849 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $214,297 | 66,968 | Shares | Defined | 2022-10-27 | |
| 2022-06-30 | $264,081 | 69,495 | Shares | Defined | 2022-08-01 | |
| 2022-03-31 | $1,260,375 | 233,836 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $3,137,264 | 232,218 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,442,620 | 247,362 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $4,637,712 | 270,263 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $5,385,880 | 269,294 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $4,675,408 | 275,024 | Shares | Defined | 2021-02-04 | |
| 2020-09-30 | $3,137,218 | 189,103 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $2,037,639 | 87,981 | Shares | Defined | 2020-08-07 | |
| 2020-03-31 | $1,572,959 | 88,121 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||